Peter Samuel Wulff

Inagen ApS is a holding company that develops novel biopharmaceuticals for anti-viral treatment opportunities. Its primary candidate is treatment for Cytomegalovirus (CMV). The technology utilizes a "self targeting capability", which takes place in the natural defense mechanism of the specific disease, to target and kill infected cells. Its platform technology can be utilized to target numerous infectious diseases. The company was founded by Thomas Nitschke Kledal l in 2007 and is headquartered in Lyngby, Denmark.

Ferrosan ApS manufactures and sells pharmaceutical products. Its products include herbal medicine, natural remedies, food supplements, and medical devices. The company was founded by Niels Jacob Herman Weitzmann in 1920 and is headquartered in Ballerup, Denmark.

MedArt A/S aim to be your preferred partner within laser based treatments for surgical and aesthetic applications. More than 25 years of experience in the manufacturing of super compact, high performance diode and C02 lasers combined with scanning technology have provided doctors and clinics world-wide with high-performance equipment for strong patient satisfaction. Their unique combination of clinical understanding and proprietary technology has formed the background of their company and the MedArt® brand-medical art based on scientific research.

Dansk Biotek is an industry association for biotech companies with promoting the biotechnological research, development and production in taking care of corporate interests in this regard, both nationally and internationally. The company was founded in 1987 and is headquartered in Copenhagen, Denmark.

IMSK SE engages in the provision of marine transportation services and maritime solutions. It also provides logistics solutions for the regional distribution of liquefied gases. The company was founded on November 12, 1996 and is headquartered in Oslo, Norway.

Sentinext Therapeutics Sdn. Bhd. develops vaccines and therapeutics for tropical infectious diseases. Its pharmaceutical research and development focuses on EV71, polio, influenza and dengue diseases. The company was founded by Mary Jane Cardosa and Peter Samuel Wulff in 2009 and is headquartered in Penang, Malaysia.